A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea

被引:7
|
作者
Chen, Yufan [1 ]
Watson, Tina R. [1 ]
Criss, Steven D. [1 ]
Eckel, Andrew [1 ]
Palazzo, Lauren [1 ]
Sheehan, Deirdre F. [1 ,3 ]
Kong, Chung Yin [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
来源
PLOS ONE | 2019年 / 14卷 / 07期
基金
美国国家卫生研究院;
关键词
SMOKING PREVALENCE; UNITED-STATES; MORTALITY; TRENDS; CT; OUTCOMES; PROGRAM; MODELS; IMPACT; NLST;
D O I
10.1371/journal.pone.0220610
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
More than 50% of the world's lung cancer cases occur in Asia and more than 20% of cancer deaths in Asia are attributable to lung cancer. The U. S. National Lung Screening Trial has shown that lung cancer screening with computed tomography ( CT) can reduce lung cancer deaths. Using the Lung Cancer Policy Model-Asia ( LCPM-Asia), we estimated the potential mortality reduction achievable through the implementation of CT-based lung cancer screening in China, Japan, Singapore, and South Korea. The LCPM-Asia was calibrated to the smoking prevalence of each of the aforementioned countries based on published national surveys and to lung cancer mortality rates from the World Health Organization. The calibrated LCPM-Asia was then used to simulate lung cancer deaths under screening and no-screening scenarios for the four countries. Using screening eligibility criteria recommended by the U. S. Centers for Medicare & Medicaid Services ( CMS), which are based on age and smoking history, we estimated the lung cancer mortality reduction from screening through year 2040. By 2040, lung cancer screening would result in 91,362 life-years gained and 4.74% mortality reduction in South Korea; 290,325 life-years gained and 4.33% mortality reduction in Japan; 3,014,215 life-years gained and 4.22% mortality reduction in China; and 8,118 life-years gained and 3.76% mortality reduction in Singapore. As for mortality reduction by smoker type, current smokers would have the greatest mortality reduction in each country, ranging from 5.56% in Japan to 6.86% in Singapore. Among the four countries, lung cancer screening under CMS eligibility criteria was most effective in South Korea and least effective in Singapore. Singapore's low smoking prevalence and South Korea's aging population and higher smoking prevalence may partially explain the discrepancy in effectiveness. CT screening was shown to be promising as a means of reducing lung cancer mortality in the four countries.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Colorectal cancer mortality in Hong Kong of China, Japan, South Korea, and Singapore
    Shin, Aesun
    Jung, Kyu-Won
    Won, Young-Joo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) : 979 - 983
  • [2] Colorectal cancer mortality in Hong Kong of China,Japan,South Korea,and Singapore
    Aesun Shin
    Kyu-Won Jung
    Young-Joo Won
    [J]. World Journal of Gastroenterology, 2013, (07) : 979 - 983
  • [3] Comparison of Lung Cancer Screening Trials from East Asia; South Korea, Japan, and Taiwan
    Shin, S. W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S531 - S531
  • [4] THE EFFECT OF NATIONWIDE ORGANIZED CANCER SCREENING PROGRAMS ON GASTRIC CANCER MORTALITY: A SYNTHETIC CONTROL STUDY FOR SOUTH KOREA AND JAPAN
    Sun, Dianqin
    Mulder, Duco T.
    Nieboer, Daan
    O'Mahony, James F.
    Lansdorp-Vogelaar, Iris
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S196 - S197
  • [5] The effect of the rise of China on Taiwan, Japan, and South Korea
    Nanto, DK
    Chanlett-Avery, E
    [J]. PROBLEMS OF POST-COMMUNISM, 2006, 53 (01) : 33 - 47
  • [6] Disparities in Gastric Cancer Screening: A Comparative Analysis of Japan and South Korea
    Shiratori, Yasutoshi
    Ishii, Naoki
    Kalloo, Anthony
    [J]. GASTROENTEROLOGY, 2024, 167 (04) : 815 - 816
  • [7] A SIMULATION STUDY OF THE EFFECT OF SCREENING ON LUNG CANCER MORTALITY IN ASIA
    Chen, Y.
    Criss, S. D.
    Sheehan, D. F.
    Kong, C. Y.
    [J]. VALUE IN HEALTH, 2018, 21 : S23 - S23
  • [8] Cancer burden and trends in China: A review and comparison with Japan and South Korea
    Dianqin Sun
    Maomao Cao
    He Li
    Siyi He
    Wanqing Chen
    [J]. Chinese Journal of Cancer Research, 2020, 32 (02) : 129 - 141
  • [9] Trends in incidence and overdiagnosis of thyroid cancer in China, Japan, and South Korea
    Lin, Yongtian
    Wu, Yu
    [J]. CANCER SCIENCE, 2023, 114 (10) : 4052 - 4062
  • [10] Cancer burden and trends in China: A review and comparison with Japan and South Korea
    Sun, Dianqin
    Cao, Maomao
    Li, He
    He, Siyi
    Chen, Wanqing
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (02) : 129 - +